MedTrace Logo

Therapeutic Recommendations for Nephroblastoma

NCT04423484 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-03-02

No results posted yet for this study

Summary

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

Conditions

  • Nephroblastoma

Interventions

OTHER

Data collection

Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.

Sponsors & Collaborators

  • French Africa Pediatric Oncology Group

    lead OTHER

Principal Investigators

  • Fatou Binetou Ms DIAGNE AKONDE, Dr · French Africa Pediatric Oncology Group

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2028-12-31
Completion
2030-12-30

Countries

  • Burkina Faso
  • Côte d’Ivoire
  • Democratic Republic of the Congo
  • Madagascar
  • Mali
  • Senegal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04423484 on ClinicalTrials.gov